Charcot Neuroarthropathy

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Citação
Sposeto, R. B.; Godoy-Santos, A. L.. Charcot Neuroarthropathy. In: . Foot and Ankle Disorders: A Comprehensive Approach in Pediatric and Adult Populations: SPRINGER INTERNATIONAL PUBLISHING, 2022. p.985-1004.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Charcot’s Neuroarthropathy (CN) is a serious pathology, with devastating impact on mobility and quality of life of the patient. Although its pathophysiology is not completely clear, it is related to sensory neuropathy, repetitive trauma, and increased expression of pro-inflammatory cytokines. Currently, Diabetes Mellitus (DM) is the disease most related to this pathology. The pathology begins with intense inflammation, associated with fractures and cumulative and progressive dislocations, mainly in the foot and ankle. At the end of the inflammatory phase, bone healing occurs, and the residual deformity is established. The objective of the treatment is to obtain a functional plantigrade foot at the end of the four clinical phases. The initial approach is to protect the foot in the inflammatory phase to avoid progression of the fractures and deformity. After the consolidation phase in case the patient does not adapt to the modification of footwear and orthotics, the surgical treatment for foot realignment should be indicated. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.
Palavras-chave
arthrodesis, Charcot neuroarthropathy, Diabetes, neuropathy, treatment
Referências
  1. Crim B.E., Lowery N.J., Wukich D.K., Internal fixation techniques for midfoot Charcot neuroarthropathy in patients with diabetes, Clin Podiatr Med Surg [Internet], 28, pp. 673-685, (2011)
  2. Dardari D., An overview of Charcot’s neuroarthropathy, J Clin Transl Endocrinol, (2020)
  3. Labovitz J.M., Shofler D.W., Ragothaman K.K., The impact of comorbidities on inpatient Charcot neuroarthropathy cost and utilization, J Diabetes Complications [Internet], 30, pp. 710-715, (2016)
  4. Chaudhary S., Bhansali A., Rastogi A., Mortality in Asian Indians with Charcot’s neuroarthropathy: A nested cohort prospective study, Acta Diabetol [Internet], 56, pp. 1259-1264, (2019)
  5. Singh D., Gray J., Laura M., Reilly M.M., Charcot neuroarthropathy in patients with Charcot Marie Tooth Disease, Foot Ankle Surg, (2020)
  6. Gupta R., A short history of neuropathic arthropathy, Clin Orthop Relat Res, pp. 43-49, (1993)
  7. Jordan W.R., Neuritic manifestations in diabetes mellitus, Arch Int Med, 57, pp. 307-366, (1936)
  8. Johnson-Lynn S.E., McCaskie A.W., Coll A.P., Robinson A.H.N., Neuroarthropathy in diabetes: Pathogenesis of charcot arthropathy, Bone Joint Res, 7, pp. 373-378, (2018)
  9. Dodd A., Daniels T.R., Charcot neuroarthropathy of the foot and ankle, J Bone Joint Surg Am, 100, pp. 696-711, (2018)
  10. Frykberg R.G., Belczyk R., Epidemiology of the Charcot foot [Internet], Clinics in podiatric medicine and surgery, 25, pp. 17-28, (2008)
  11. O'Loughlin A., Kellegher E., McCusker C., Canavan R., Diabetic charcot neuroarthropathy: Prevalence, demographics and outcome in a regional referral centre, Ir J Med Sci, 186, pp. 151-156, (2017)
  12. Schneekloth B.J., Lowery N.J., Wukich D.K., Charcot neuroarthropathy in patients with diabetes: An updated systematic review of surgical management, J Foot Ankle Surg [Internet], 55, pp. 586-590, (2016)
  13. Yates T.H., Cooperman S.R., Shofler D., Agrawal D.K., Current concepts underlying the pathophysiology of acute Charcot neuroarthropathy in the diabetic foot and ankle, Expert Rev Clin Immunol [Internet], 16, pp. 839-845, (2020)
  14. Botek G., Figas S., Narra S., Charcot neuroarthropathy advances: Understanding pathogenesis and medical and surgical management, Clin Podiatr Med Surg [Internet], 36, pp. 663-684, (2019)
  15. Petrova N.L., Foster A.V.M., Edmonds M.E., Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: Differences between type 1 and type 2 diabetes, Diabet Med [Internet], 22, pp. 756-761, (2005)
  16. Barwick A.L., de Jonge X.A.K.J., Tessier J.W., Ho A., Chuter V.H., The effect of diabetic neuropathy on foot bones: A systematic review and meta-analysis, Diabet Med [Internet], 31, pp. 136-147, (2014)
  17. Jeffcoate W.J., Game F., Cavanagh P.R., The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes, Lancet, 366, pp. 2058-2061, (2005)
  18. Pasquier J., Spurgeon M., Bradic M., Thomas B., Robay A., Chidiac O., Et al., Whole-methylome analysis of circulating monocytes in acute diabetic Charcot foot reveals differentially methylated genes involved in the formation of osteoclasts, Epigenomics, 11, pp. 281-296, (2019)
  19. Pasquier J., Thomas B., Hoarau-Vechot J., Odeh T., Robay A., Chidiac O., Et al., Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction, Sci Rep, (2017)
  20. Jansen R.B., Svendsen O.L., A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot [Internet], J Diabetes Complications, 32, pp. 708-712, (2018)
  21. Ndip A., Williams A., Jude E.B., Serracino-Inglott F., Richardson S., Smyth J.V., Et al., The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic charcot neuroarthropathy, Diabetes, 60, pp. 2187-2196, (2011)
  22. Jansen R.B., Christensen T.M., Bulow J., Rordam L., Holstein P.E., Jorgensen N.R., Et al., Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study, J Diabetes Complications, 32, pp. 164-170, (2018)
  23. Shibata T., Tada K., Hashizume C., The results of athrodesis of the ankle for leprotic neuroarthropathy, J Bone Joint Surg Ser A, 72, pp. 749-756, (1990)
  24. Yu G.V., Hudson J.R., Evaluation and treatment of stage 0 Charcot’s neuroarthropathy of the foot and ankle, J Am Podiatr Med Assoc, 92, pp. 210-220, (2002)
  25. Moura-Neto A., Fernandes T.D., Zantut-Wittmann D.E., Trevisan R.O., Sakaki M.H., Santos A.L.G., Et al., Charcot foot: Skin temperature as a good clinical parameter for predicting disease outcome, Diabetes Res Clin Pract, 96, pp. 4-7, (2012)
  26. Pitocco D., Scavone G., Di Leo M., Vitiello R., Rizzi A., Tartaglione L., Et al., Charcot Neuroarthropathy: From the laboratory to the bedside, Curr Diabetes Rev, 16, pp. 62-72, (2019)
  27. Idusuyi O.B., Surgical management of Charcot neuroarthropathy, Prosthetics Orthot Int, 39, pp. 61-72, (2015)
  28. Diretrizes do IWGDF sobre a prevenção e o tratamento de pé diabético, (2019)
  29. Palestro C.J., Mehta H.H., Patel M., Freeman S.J., Harrington W.N., Tomas M.B., Et al., Marrow versus infection in the Charcot joint: Indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy, J Nucl Med, 39, pp. 346-350, (1998)
  30. Zhuang H., Duarte P.S., Pourdehand M., Shnier D., Alavi A., Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging, Clin Nucl Med, 25, pp. 281-284, (2000)
  31. Hastings M.K., Johnson J.E., Strube M.J., Hildebolt C.F., Bohnert K.L., Prior F.W., Et al., Progression of foot deformity in Charcot neuropathic osteoarthropathy, J Bone Jt Surg-Ser A [Internet], 95, pp. 1206-1213, (2013)
  32. Hopfner S., Krolak C., Kessler S., Tiling R., Brinkbaumer K., Hahn K., Et al., Preoperative imaging of charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging, Foot Ankle Int, 25, pp. 890-895, (2004)
  33. Pinzur M., Surgical versus accommodative treatment for charcot arthropathy of the midfoot [Internet], Foot and ankle international, 25, pp. 545-549, (2004)
  34. Parisi M.C.R., Godoy-Santos A.L., Ortiz R.T., Sposeto R.B., Sakaki M.H., Nery M., Et al., Radiographic and functional results in the treatment of early stages of Charcot neuroarthropathy with a walker boot and immediate weight bearing, Diabet Foot Ankle, (2013)
  35. Pinzur M.S., Lio T., Posner M., Treatment of Eichenholtz stage I Charcot foot arthropathy with a weight-bearing total contact cast, Foot Ankle Int, 27, pp. 324-329, (2006)
  36. Christensen T.M., Gade-Rasmussen B., Pedersen L.W., Hommel E., Holstein P.E., Svendsen O.L., Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker, J Diabetes Complications, 26, pp. 430-434, (2012)
  37. Sella E.J., Barrette C., Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient, J Foot Ankle Surg, 38, pp. 34-40
  38. Simon S.R., Tejwani S.G., Wilson D.L., Santner T.J., Denniston N.L., Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot, J Bone Jointt Surg Ser A, 82, pp. 939-950, (2000)
  39. Rettedal D., Parker A., Popchak A., Burns P.R., Prognostic scoring system for patients undergoing reconstructive foot and ankle surgery for Charcot neuroarthropathy: The Charcot reconstruction preoperative prognostic score, J Foot Ankle Surg [Internet], 57, pp. 451-455, (2018)
  40. LaPorta G.A., D'Andelet A., Lengthen, alignment, and beam technique for midfoot Charcot neuroarthropathy, Clin Podiatr Med Surg [Internet], 35, pp. 497-507, (2018)
  41. Laurinaviciene R., Kirketerp-Moeller K., Holstein P.E., Exostectomy for chronic midfoot plantar ulcer in Charcot deformity, J Wound Care, 17, pp. 53-55, (2008)
  42. Sammarco V.J., Superconstructs in the treatment of charcot foot deformity: Plantar plating, locked plating, and axial screw fixation, Foot Ankle Clin, 14, pp. 393-407, (2009)
  43. Connors J.C., Hardy M.A., Kishman L.L., Botek G.G., Verdin C.J., Rao N.M., Et al., Charcot pathogenesis: A study of in vivo gene expression, J Foot Ankle Surg, 57, pp. 1067-1072, (2018)
  44. Simonik M.M., Wilczek J., LaPorta G., Willing R., Biomechanical comparison of intramedullary beaming and plantar plating methods for stabilizing the medial column of the foot: An in vitro study, J Foot Ankle Surg [Internet], 57, pp. 1073-1079, (2018)
  45. Pope E.J., Takemoto R.C., Kummer F.J., Mroczek K.J., Midfoot fusion: A biomechanical comparison of plantar planting vs intramedullary screws, Foot Ankle Int, 34, pp. 409-413, (2013)
  46. Conway J.D., Charcot salvage of the foot and ankle using external fixation, Foot and ankle clinics. Foot Ankle Clin, 13, pp. 157-173, (2008)
  47. Lowery N.J., Woods J.B., Armstrong D.G., Wukich D.K., Surgical management of Charcot neuroarthropathy of the foot and ankle: A systematic review, Foot Ankle Int, 33, pp. 113-121, (2012)
  48. Shazadeh Safavi P., Jupiter D.C., Panchbhavi V., A systematic review of current surgical interventions for Charcot neuroarthropathy of the midfoot, J Foot Ankle Surg [Internet], 56, pp. 1249-1252, (2017)
  49. Grant W.P., Garcia-Lavin S.E., Sabo R.T., Tam H.S., Jerlin E., A retrospective analysis of 50 consecutive Charcot diabetic salvage reconstructions, J Foot Ankle Surg, 48, pp. 30-38, (2009)